Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05742386 · ClinicalTrials.gov registry record · NA
Impact of Standing Orders Optimization
A NA study of Human Papilloma Virus, sponsored by UNC Lineberger Comprehensive Cancer Center.
- Active
- Registry status
- NA
- Development phase
- 28
- Enrollment target
- 1
- Study location
NCT05742386: Active NA study of Human Papilloma Virus, sponsored by UNC Lineberger Comprehensive Cancer Center.
NCT05742386 is a NA study of Human Papilloma Virus that is active but no longer recruiting, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 28 participants, below the 8,441-participant average among 39 other Human Papilloma Virus trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05742386, a NA study of Human Papilloma Virus, is active but no longer recruiting, sponsored by UNC Lineberger Comprehensive Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
- 1
- Study location
Study Summary
This trial will look at the impact of optimizing human papillomavirus (HPV) vaccine standing orders. The research team will work with primary care clinics. Some clinics will receive communication training. Other clinics will receive the same training and tools for increasing the use of their standing orders.
Primary Outcome
Proportion of unvaccinated children who initiate the HPV vaccine series between baseline and 12-month follow-up, among those who were ages 9-12 at baseline.
Conditions Studied
Interventions
- BEHAVIORAL Communication training
- BEHAVIORAL Communication training enhanced with standing orders optimization
Study Locations (1)
North Carolina
- The University of North Carolina at Chapel Hill - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2023-02-22 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What the registry record for NCT05742386 still lists
NCT05742386 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 8,441-participant average among 39 other Human Papilloma Virus trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Human Papilloma Virus appearing as the primary indexed condition, and to 2 interventions - of which Communication training is the first listed.
NCT05742386 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT05742386 about?
NCT05742386 is a clinical study titled "Impact of Standing Orders Optimization". This trial will look at the impact of optimizing human papillomavirus (HPV) vaccine standing orders. The research team will work with primary care clinics. Some clinics will receive communication training. Other clinics will receive the same training and tools for increasing the use of their standin...
What is the current status of trial NCT05742386?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 28 participants. The study started on 2023-02-22. Estimated completion is 2026-12-31.
What conditions does trial NCT05742386 study?
This clinical trial studies the following conditions: Human Papilloma Virus.
What interventions are being tested in trial NCT05742386?
The interventions under investigation include: Communication training (BEHAVIORAL), Communication training enhanced with standing orders optimization (BEHAVIORAL).
Who is sponsoring clinical trial NCT05742386?
This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05742386 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Human Papilloma Virus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05742386's enrollment target sits among peer trials
28 37th of 39 higher than 3 of 39 other Human Papilloma Virus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Human Papilloma Virus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Educate and Improve Underserved Populations' Uptake and Completion of the HPV Vaccine
RECRUITING · NA
-
PopSci CHW4CervixHealth
RECRUITING · NA
-
Advancing HPV Vaccination Among HIV Positive Adults: The CHAMPS Study
RECRUITING · NA
-
Provider Recommendation and HPV Vaccination
RECRUITING · NA
-
Development of a Self-collection Device for Cervical Cancer Screening
ACTIVE NOT RECRUITING · NA
-
Impact of Financial Incentives
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI